Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Chinese biopharma developing and selling cancer and blood-disorder drugs

What Dizal does

Dizal discovers, develops and sells medicines for cancer and blood disorders. It already has drugs on the market, including ZEGFROVY for solid tumors, and several more candidates in development. It was founded in 2017 and is based in Shanghai.

How Dizal makes money

Dizal earns revenue by selling its approved drugs, such as ZEGFROVY and Gao Ruizhe, for cancer and blood-disorder treatment. It puts that money into research on its pipeline of new candidate drugs.

Products & services

• ZEGFROVY
• Gao Ruizhe (高瑞哲)
• Birelentinib
• DZD2269
• DZD1516
• DZD6008
• GW5282